Dialysis industry news

Stories from the dialysis comunity across the globe.



NxStage System One Now in Eight of Top 10 US Nephrology Hospitals - MarketWatch PDF Print


                  LAWRENCE, Mass., Aug. 12, 2015 /PRNewswire/ -- NxStage Medical, Inc. 

                            
                            
                                  
      
      
      
      
      
      
      
                                  
                                    NXTM, +3.67%

                            
                                  
      
      
      
      
      
      
      
                                         a leading manufacturer of dialysis products, today announced that the NxStage® System One™ is now used in eight of the Top 10 Nephrology Hospitals in the United States as ranked according to U.S. News & World Report. The Company's revolutionary System One simplifies care in acute settings and allows renal care professionals to deliver the prescribed renal replacement therapy via a variety of modalities to critically ill patients.


                  The System One offers multiple features designed to simplify therapies in hospitals. These features include the NxView interface with graphical touch screen display that provides treatment information and charting assistance, a drop-in cartridge that allows multiple therapies, no waste bags, and no special electrical or plumbing needs.


                  "We're honored to be a partner to these prestigious hospitals, and we look forward to continued close collaboration as we deliver future innovations to patient care," said Joseph E. Turk, President of NxStage.


                  For more information about the NxStage System One, renal replacement therapies or home hemodialysis, please visit www.nxstage.com.


                  
        Renal replacement therapy, as with any medical therapy, is not without risks. The decision of which therapy to use should be made by the physician, based on previous experience and on the individual facts and circumstances of the patient.  
      

                  
        About the NxStage System OneThe System One is used to provide a range of flexible therapy options in hospitals and dialysis centers.  The NxStage System One is also the first and only truly portable hemodialysis system cleared specifically by the FDA for home hemodialysis and home nocturnal hemodialysis. Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy. When combined with the NxStage PureFlow SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid on demand. Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs, including while they are sleeping - at home or on vacation and at a medically appropriate treatment frequency. Its safety and efficacy have been demonstrated by experience with more than 10 million treatments with thousands of patients around the world. http://www.nxstage.com/.


                  
        About NxStage MedicalNxStage Medical Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.


                  
        Forward-Looking StatementsThis release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended June 30, 2015. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.


                  
        Media contact:   
Kristen K. Sheppard, Esq.
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Tel: (978) 332-5923   Logo - http://photos.prnewswire.com/prnh/20110503/MM94799LOGO Logo - http://photos.prnewswire.com/prnh/20150624/225341 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nxstage-system-one-now-in-eight-of-top-10-us-nephrology-hospitals-300127263.html SOURCE NxStage Medical, Inc. Copyright (C) 2015 PR Newswire. All rights reserved

...

 
Only 1 in 4 patients with ESRD in Georgia referred for kidney transplant ... - News-Medical.net PDF Print

Only about one in four patients with end-stage renal disease in Georgia were referred for kidney transplant evaluation within 1 year of starting dialysis between 2005 and 2011, although there was substantial variability in referral among dialysis facilities, according to a study in the August 11 issue of JAMA.

For most of the more than 600,000 patients in the United States with end-stage renal disease (ESRD), kidney transplantation represents the optimal treatment, providing longer survival, better quality of life, and substantial cost savings compared with dialysis. Dialysis facilities in the United States are required to educate patients with ESRD about all treatment options, including kidney transplantation. Patients receiving dialysis typically require a referral for kidney transplant evaluation at a transplant center to begin the transplantation process, but the proportion of dialysis patients referred for transplantation has been unknown, according to background information in the article.

Rachel E. Patzer, Ph.D., M.P.H., of the Emory University School of Medicine, Atlanta, and colleagues examined variation in dialysis facility-level referral for kidney transplant evaluation and factors associated with referral among patients initiating dialysis in Georgia, the U.S. state with the lowest kidney transplantation rates. The study included data from the United States Renal Data System for 15,279 adult (18-69 years) patients with ESRD from 308 Georgia dialysis facilities from January 2005 to September 2011, followed up through September 2012, and linked to kidney transplant referral data collected from adult transplant centers in Georgia in the same period.

The median within-facility percentage of patients referred within 1 year of starting dialysis at 308 Georgia dialysis facilities was 24 percent. There were 15 facilities (5 percent) that referred zero patients within 1 year of starting dialysis; the maximum referral in a year was 75 percent. Facilities in the lowest tertile of referral (<19 percent) were more likely to treat patients living in high-poverty neighborhoods, had a higher patient to social worker ratio, and were more likely nonprofit compared with facilities in the highest tertile of referral (>31 percent).

Factors associated with lower referral for transplantation, such as white race, older age, and nonprofit facility status, were not necessarily the same as those associated with lower waitlisting, the researchers write. "Results of this study suggest that referral for transplantation among Georgia dialysis facilities is not uniform and that national surveillance data measuring waitlisting and transplantation, but not referral, may be inadequate to assess and intervene on disparities in access to kidney transplantation."

"These findings may have implications for health policy makers, researchers, clinicians, and patients. Low facility-level referral for transplantation, as well as the variability in referral across Georgia facilities, suggests that standardized guidelines are needed for the content and duration of a patient-clinician educational discussion regarding treatment options at start of dialysis. Socioeconomic status factors were significant barriers to both referral and waitlisting in this study; national policies, such as Medicaid expansion, could help to alleviate disparities," the authors write.

"Researchers should continue to develop, test, and implement pragmatic interventions to improve knowledge of transplantation among both clinicians and patients. In Georgia, such interventions could focus on those dialysis facilities with the lowest proportions of patients with ESRD referred for kidney transplantation."

"In summary, this important report by Patzer et al has established that major barriers in access to transplantation exist even after a patient has been referred to a transplant center, with 80 percent of referred patients not joining the transplant waitlist within 1 year of referral," writes Dorry L. Segev, M.D., Ph.D., and colleagues with the Johns Hopkins University School of Medicine, Baltimore, in an accompanying editorial.

"Furthermore, the initial rates of referral were likely low and varied widely between dialysis centers, suggesting that some facilities may have been underreferring patients. Future research to better understand and target post-referral barriers, as well as interventions to identify and improve referral rates in the context of comprehensive transplant education, will be crucial for improving access to kidney transplantation for patients with ESRD."

The JAMA Network Journals

...

 
End-stage renal disease incidence plateaus for now - Managed Care magazine PDF Print

The Evolving Biosimilars’ Landscape

Explore the complexities of the biosimilars’ landscape, such as naming, interchangeability and substitution, differences in the manufacturing processes, as well as the approval pathways & FDA guidelines for biologics, including draft guidance on biosimilars.

USA-BIO-106112

...

 
Housewife goes missing after dialysis, seen making payment at hosp counter on CCTV - Times of India PDF Print

Daily News & Analysis

Housewife goes missing after dialysis, seen making payment at hosp counter on CCTV
Times of India
THANE: A 55-year-old housewife from Thane (E), who had gone for dialysis at Fortis Hospital in Mulund, has gone missing since Monday morning. The Tilwani family and friends expressed shocked over her disappearance and have lodged a missing ...
Thane resident goes missing from Fortis hospital after dialysis Daily News & Analysis

all 4 news articles »

...

 
Georgia dialysis facility referral rate for kidney transplants is low and variable - Emory News Center PDF Print

Although kidney transplantation is known to be the optimal treatment for most patients with end-stage renal disease (ESRD), only about one in four patients with ESRD in Georgia was referred by a dialysis facility to a transplant center for evaluation within one year of starting dialysis, according to a new study. In addition, there was substantial variation in the percentage of referrals among dialysis facilities.

The study of patients in Georgia dialysis facilities between 2005 and 2011 was led by Rachel Patzer, PhD, MPH, assistant professor of surgery in Emory University School of Medicine and Rollins School of Public Health and is published in the Journal of the American Medical Association (JAMA).

For the majority of the more than 600,000 patients in the US who have ESRD, kidney transplantation offers longer survival, better quality of life and lower costs compared to the alternative treatment of dialysis.

“Georgia has the lowest kidney transplant rates of any state in the nation, and our research team wanted to find out whether this low rate was related to how dialysis centers refer patients to transplant centers,” says Patzer.

The Centers for Medicare and Medicaid Services (CMS) requires U.S. dialysis facilities to educate patients with ESRD about all treatment options, including transplantation, and referral to a transplant center to start the transplant medical evaluation is the next step to initiate the process.

The researchers analyzed data from 15,279 adult patients with ESRD at 308 Georgia dialysis facilities from January 2005 to September 2011, followed through September 2012. They linked those data to referrals received by the three kidney transplant centers in Georgia and wait-listing of patients for transplant.

The median within-facility percentage of patients referred by the dialysis centers within one year of starting dialysis was 24.4 percent, but the percentage referred varied between zero patients and 75 percent of patients. Facilities with the lowest percentage of referrals were more likely to treat patients living in high-poverty neighborhoods, had a higher patient-to-social worker ratio, and were more likely to be nonprofit compared to the facilities with the highest percentage of referrals.

Factors associated with a lower percentage of referrals for transplant also included older age and white race, but these factors were not always the same as those associated with lower rates of waitlisting.

“Variability in dialysis facility referral may be contributing to the inequities in access to kidney transplantation that we and others have already found,” says Patzer. “Our study shows the need to analyze all the steps leading to kidney transplant in order to determine the reasons for low rates of transplant as well as disparities. For example, we found that black patients were referred for evaluation more often than white patients, but that a greater percentage of white patients were waitlisted after referral. There may be a variety of reasons for this difference, but without data on dialysis facility referrals, we might have concluded that these disparities began during the referral stage.”

The study notes that referrals may be limited by the fact that nephrologists and dialysis facility staff are unsure about which patients to refer for transplantation, and dialysis professionals may need more guidance about appropriate referrals. Despite the CMS requirement that dialysis facilities educate their patients about transplantation and track referrals, other studies have found that nationally, fewer than 50 percent of nephrologists have a detailed discussion about transplantation with their patients and only 33 percent of patients are informed about transplant options when they begin dialysis.

The authors believe their findings may have implications for health policy makers, researchers, clinicians and patients. The low percentage of facility referrals and variability across Georgia suggests that standardized guidelines and national policies are needed for patient education regarding treatment options when dialysis begins.

“Researchers should continue to develop, test and implement interventions to improve knowledge about transplantation among clinicians and patients,” they say, with a special focus on dialysis facilities with the lowest percentage of patients with ESRD referred for kidney transplantation.

“Interventions are important in the Southeastern U.S., where we have the lowest access to kidney transplantation in the nation,” Patzer says.

However, there are no national data on referral. Patzer noted that it was only due to the collaboration of all of the transplant centers in the state through their Southeastern Kidney Transplant Coalition partnership that these data were able to be studied in Georgia. 

“Our data emphasize the importance of measuring referral for transplantation to capture its variability both within and between regions,” say the authors. “Because we found that factors associated with referral and waitlisting may differ, it is important to highlight possible discrepancies between dialysis facilities’ perceptions of appropriate referrals and the reality of which patients are actually waitlisted and undergo transplantation in practice. National data collection on referral is needed to examine whether findings in Georgia are generalizable to other regions of the country.”

The research was funded by the National Institute on Minority Health and Health Disparities, grant #R24MD008077.

...

 
<< Start < Prev 21 22 23 24 25 26 27 28 29 30 Next > End >>

Page 25 of 4210
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.